Expected and Actual Case Ascertainment and Treatment Rates for Children Infected with Hepatitis C in Florida and the United States: Epidemiologic Evidence from Statewide and Nationwide Surveys

Objective To evaluate the rate of pediatric hepatitis C virus (HCV) case ascertainment relative to the estimated number of actual cases. Study design Data from Florida and United States health departments were used to assess pediatric HCV case ascertainment rates in Florida and nationwide. The perce...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pediatrics Vol. 161; no. 5; pp. 915 - 921
Main Authors Delgado-Borrego, Aymin, MD, MPH, Smith, Lesley, MD, Jonas, Maureen M., MD, Hall, Cyndena A., BA, Negre, Betania, MD, Jordan, Sergio H., MD, Ogrodowicz, Matthew, Raza, Roshan, MD, Ludwig, David A., PhD, Miller, Tracie, MD, Lipshultz, Steven E., MD, Gonzalez-Peralta, Regino, MD, Chung, Raymond T., MD
Format Journal Article
LanguageEnglish
Published Maryland Heights, MO Elsevier Inc 01.11.2012
Mosby, Inc
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective To evaluate the rate of pediatric hepatitis C virus (HCV) case ascertainment relative to the estimated number of actual cases. Study design Data from Florida and United States health departments were used to assess pediatric HCV case ascertainment rates in Florida and nationwide. The percentage of children infected with HCV from Miami-Dade County receiving medical care by a pediatric gastroenterologist was estimated based on data obtained from physician questionnaires. Results From 2000 through 2009, 2007 children were identified as having positive HCV antibody tests in Florida, only 12% of the expected number (n = 12 155). An estimated 1.6% of the expected children with HCV who tested Ab-positive (37 of 1935) were actively followed by a pediatric gastroenterologist in Miami-Dade County, Florida. Across the United States, only 4.9% of the expected cases have been identified. Conclusions The identification of children infected with HCV in the nation as a whole is grossly inadequate. Only a small fraction of cases are identified. In Florida, less than 2% of children identified receive treatment. Lack of identification and lack of treatment of children infected with HCV constitute critical public health problems. Strategies to increase awareness of HCV infection and to screen at-risk individuals could substantially improve morbidity and mortality while reducing health care costs.
AbstractList To evaluate the rate of pediatric hepatitis C virus (HCV) case ascertainment relative to the estimated number of actual cases. Data from Florida and United States health departments were used to assess pediatric HCV case ascertainment rates in Florida and nationwide. The percentage of children infected with HCV from Miami-Dade County receiving medical care by a pediatric gastroenterologist was estimated based on data obtained from physician questionnaires. From 2000 through 2009, 2007 children were identified as having positive HCV antibody tests in Florida, only 12% of the expected number (n = 12 155). An estimated 1.6% of the expected children with HCV who tested Ab-positive (37 of 1935) were actively followed by a pediatric gastroenterologist in Miami-Dade County, Florida. Across the United States, only 4.9% of the expected cases have been identified. The identification of children infected with HCV in the nation as a whole is grossly inadequate. Only a small fraction of cases are identified. In Florida, less than 2% of children identified receive treatment. Lack of identification and lack of treatment of children infected with HCV constitute critical public health problems. Strategies to increase awareness of HCV infection and to screen at-risk individuals could substantially improve morbidity and mortality while reducing health care costs.
OBJECTIVETo evaluate the rate of pediatric hepatitis C virus (HCV) case ascertainment relative to the estimated number of actual cases.STUDY DESIGNData from Florida and United States health departments were used to assess pediatric HCV case ascertainment rates in Florida and nationwide. The percentage of children infected with HCV from Miami-Dade County receiving medical care by a pediatric gastroenterologist was estimated based on data obtained from physician questionnaires.RESULTSFrom 2000 through 2009, 2007 children were identified as having positive HCV antibody tests in Florida, only 12% of the expected number (n = 12 155). An estimated 1.6% of the expected children with HCV who tested Ab-positive (37 of 1935) were actively followed by a pediatric gastroenterologist in Miami-Dade County, Florida. Across the United States, only 4.9% of the expected cases have been identified.CONCLUSIONSThe identification of children infected with HCV in the nation as a whole is grossly inadequate. Only a small fraction of cases are identified. In Florida, less than 2% of children identified receive treatment. Lack of identification and lack of treatment of children infected with HCV constitute critical public health problems. Strategies to increase awareness of HCV infection and to screen at-risk individuals could substantially improve morbidity and mortality while reducing health care costs.
Objective To evaluate the rate of pediatric hepatitis C virus (HCV) case ascertainment relative to the estimated number of actual cases. Study design Data from Florida and United States health departments were used to assess pediatric HCV case ascertainment rates in Florida and nationwide. The percentage of children infected with HCV from Miami-Dade County receiving medical care by a pediatric gastroenterologist was estimated based on data obtained from physician questionnaires. Results From 2000 through 2009, 2007 children were identified as having positive HCV antibody tests in Florida, only 12% of the expected number (n = 12 155). An estimated 1.6% of the expected children with HCV who tested Ab-positive (37 of 1935) were actively followed by a pediatric gastroenterologist in Miami-Dade County, Florida. Across the United States, only 4.9% of the expected cases have been identified. Conclusions The identification of children infected with HCV in the nation as a whole is grossly inadequate. Only a small fraction of cases are identified. In Florida, less than 2% of children identified receive treatment. Lack of identification and lack of treatment of children infected with HCV constitute critical public health problems. Strategies to increase awareness of HCV infection and to screen at-risk individuals could substantially improve morbidity and mortality while reducing health care costs.
Author Delgado-Borrego, Aymin, MD, MPH
Chung, Raymond T., MD
Raza, Roshan, MD
Jonas, Maureen M., MD
Negre, Betania, MD
Lipshultz, Steven E., MD
Ogrodowicz, Matthew
Hall, Cyndena A., BA
Jordan, Sergio H., MD
Ludwig, David A., PhD
Gonzalez-Peralta, Regino, MD
Miller, Tracie, MD
Smith, Lesley, MD
Author_xml – sequence: 1
  fullname: Delgado-Borrego, Aymin, MD, MPH
– sequence: 2
  fullname: Smith, Lesley, MD
– sequence: 3
  fullname: Jonas, Maureen M., MD
– sequence: 4
  fullname: Hall, Cyndena A., BA
– sequence: 5
  fullname: Negre, Betania, MD
– sequence: 6
  fullname: Jordan, Sergio H., MD
– sequence: 7
  fullname: Ogrodowicz, Matthew
– sequence: 8
  fullname: Raza, Roshan, MD
– sequence: 9
  fullname: Ludwig, David A., PhD
– sequence: 10
  fullname: Miller, Tracie, MD
– sequence: 11
  fullname: Lipshultz, Steven E., MD
– sequence: 12
  fullname: Gonzalez-Peralta, Regino, MD
– sequence: 13
  fullname: Chung, Raymond T., MD
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26507483$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22765955$$D View this record in MEDLINE/PubMed
BookMark eNqFkt2O0zAQhSO0iP2BJ0AC3yBx02I7cX6QQKqqLrvSCiS6vbZce7J1SexgO136djwaTlJA4oYra-zvnBnN8WVyZqyBJHlJ8Jxgkr_bz_cdKD-nmNA5ZnOM6ZPkguCqmOVlmp4lF_GGztKsyM-TS-_3GOMqw_hZck5pkbOKsYvk5-pHBzKAQsIotJChFw1aCg9o4SW4ILRpwYTx9d6BCGP1VQTwqLYOLXe6UQ4MujX15POoww7dQCeCDtqjJdIGXTfWaSVGl7ADtDF6QNdh8HmPVp1W0Grb2Act0eoQKyMB1c62E_MYb0bx5-hqzViue3eAo3-ePK1F4-HF6bxKNter--XN7O7Lp9vl4m4ms7wMs6qkVGKcZxVJZZlSsa1InWVUSaVoKkBBrkpCWE7KNNuquL-6wAWkkihGCmDpVfJ28u2c_d6DD7zVcUNNIwzY3nMSxYyWGU0jmk6odNZ7BzXvnG6FO3KC-RAd3_MxOj5ExzHjMaioenVq0G9bUH80v7OKwJsTILwUTe2Ekdr_5XKGi6wc2r-euFpYLh5cZDbr2InF_MsiL8tIfJgIiAs7aHDcSz2sXGkXQ-TK6v-M-vEfvWy00XGob3AEv7e9MzELTriPGr4e_uHwDQnFmGFWpL8AuKfZ9w
CODEN JOPDAB
CitedBy_id crossref_primary_10_1097_AOG_0000000000003704
crossref_primary_10_3928_19382359_20161114_01
crossref_primary_10_36233_0372_9311_330
crossref_primary_10_1097_INF_0000000000004374
crossref_primary_10_1007_s11901_019_00468_y
crossref_primary_10_4254_wjh_v6_i9_643
crossref_primary_10_1016_S2468_1253_19_30046_9
crossref_primary_10_1186_s43054_023_00166_x
crossref_primary_10_1093_cid_ciaa949
crossref_primary_10_1016_S2055_6640_20_30500_8
crossref_primary_10_1097_MPG_0000000000002814
crossref_primary_10_1007_s11901_016_0318_6
crossref_primary_10_1111_jvh_13377
crossref_primary_10_1016_j_gtc_2015_07_011
crossref_primary_10_1002_hep_30791
crossref_primary_10_1371_journal_pone_0230109
crossref_primary_10_1097_MOP_0000000000000313
crossref_primary_10_21508_1027_4065_2019_64_6_11_19
crossref_primary_10_1093_infdis_jiaa181
crossref_primary_10_1016_j_ajog_2021_06_008
crossref_primary_10_1111_ppe_12481
crossref_primary_10_1016_S2352_4642_18_30069_5
crossref_primary_10_1097_MPG_0000000000003690
crossref_primary_10_1016_j_xagr_2024_100317
crossref_primary_10_1097_MPG_0000000000003099
crossref_primary_10_1007_s12325_020_01389_9
crossref_primary_10_1007_s40471_017_0108_x
crossref_primary_10_1097_QCO_0000000000000856
crossref_primary_10_1016_j_medcli_2016_04_003
crossref_primary_10_1111_apt_14677
crossref_primary_10_1007_s10995_017_2316_x
crossref_primary_10_1093_cid_ciw026
crossref_primary_10_1542_peds_2017_3273
crossref_primary_10_2217_fvl_2018_0147
crossref_primary_10_1016_j_jhepr_2021_100227
crossref_primary_10_1016_j_jpeds_2018_07_006
crossref_primary_10_1016_j_jpeds_2020_02_082
crossref_primary_10_1002_hep4_1028
crossref_primary_10_1111_jvh_13111
crossref_primary_10_15585_mmwr_mm6642a3
crossref_primary_10_4254_wjh_v12_i8_485
crossref_primary_10_1016_j_medcle_2016_12_021
crossref_primary_10_1097_AOG_0000000000001536
crossref_primary_10_2217_fvl_2017_0069
crossref_primary_10_1016_j_clp_2021_03_007
crossref_primary_10_1016_j_jpeds_2018_07_111
crossref_primary_10_29413_ABS_2022_7_5_2_8
crossref_primary_10_1007_s40272_018_0313_1
crossref_primary_10_1007_s10995_018_2506_1
crossref_primary_10_1002_hep4_1250
crossref_primary_10_15585_mmwr_rr7204a1
crossref_primary_10_2147_AHMT_S263864
crossref_primary_10_4254_wjh_v7_i28_2792
Cites_doi 10.1097/00043426-200111000-00012
10.1016/j.mam.2007.09.017
10.1111/j.1478-3231.2008.01934.x
10.1002/hep.510280534
10.1056/NEJM199908193410802
10.1023/B:MEBR.0000043982.17294.9b
10.1002/hep.21373
10.1002/hep.510260333
10.1002/hep.510280633
10.1345/aph.1P430
10.7326/0003-4819-144-10-200605160-00004
10.1089/apc.2009.0099
10.1016/j.jpeds.2005.10.031
10.1007/s10620-010-1412-1
10.1053/j.gastro.2010.10.047
10.1002/hep.20030
10.1002/hep.22094
10.1016/j.jhep.2010.01.016
10.1053/j.gastro.2009.09.067
10.1182/blood-2001-12-0192
10.1055/s-0028-1109296
10.3748/wjg.v13.i20.2846
10.1016/j.drugalcdep.2007.09.008
10.1053/j.gastro.2008.02.082
10.1089/apc.2010.0142
10.1097/MPG.0b013e318170af04
10.1002/hep.23561
10.1056/NEJMoa1010494
10.1093/jac/dkq157
ContentType Journal Article
Copyright 2012
2015 INIST-CNRS
Copyright © 2012. Published by Mosby, Inc.
Copyright_xml – notice: 2012
– notice: 2015 INIST-CNRS
– notice: Copyright © 2012. Published by Mosby, Inc.
DBID FBQ
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.jpeds.2012.05.002
DatabaseName AGRIS
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic



Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1097-6833
EndPage 921
ExternalDocumentID 10_1016_j_jpeds_2012_05_002
22765955
26507483
US201500087688
S0022347612005057
1_s2_0_S0022347612005057
Genre Journal Article
GeographicLocations Florida
United States
North America
America
GeographicLocations_xml – name: Florida
– name: United States
GroupedDBID ---
--K
--M
-ET
-RU
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
123
1B1
1CY
1P~
1RT
1~.
1~5
354
3O-
4.4
41~
457
4G.
53G
5RE
5VS
7-5
85S
8P~
9JM
AACTN
AAEDT
AAEDW
AAEJM
AAIKC
AAIKJ
AAKOC
AALRI
AAMNW
AAOAW
AAQFI
AAQQT
AAQXK
AAWTL
AAXKI
AAXUO
AAYJJ
ABBQC
ABFNM
ABFRF
ABIVO
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABPPZ
ABXDB
ACDAQ
ACGFO
ACGFS
ACNCT
ACRLP
ACRZS
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGNAY
AGUBO
AGYEJ
AHHHB
AI.
AIEXJ
AIKHN
AITUG
AJJEV
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
C5W
CAG
COF
CS3
DU5
EBS
EFJIC
EJD
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
G8K
GBLVA
HEF
HMK
HMO
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M27
M32
M41
MO0
N4W
N9A
NEJ
NQ-
O-L
O9-
OAUVE
OB2
OBH
OH-
OHH
OHT
OT-
OVD
P-8
P-9
P2P
PC.
PQQKQ
Q38
R2-
RIG
ROL
RPZ
SAE
SDF
SEL
SES
SEW
SJN
SPCBC
SSH
SSZ
T5K
TEORI
TWZ
UGJ
UHB
UHS
UKR
UV1
VH1
VVN
WH7
WOW
WUQ
X7M
XCE
XFW
XOL
YCJ
YFH
YOC
YOJ
YQJ
YZZ
Z5R
ZGI
ZQV
ZXP
ZY1
~G-
~KM
AAIAV
ABLVK
ABYKQ
AFDAS
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
ABPIF
AEQTP
FBQ
08R
AAUGY
AKALU
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ABDPE
ACRPL
ADNMO
CITATION
7X8
ID FETCH-LOGICAL-c468t-9822c0064913c832ab91f442dcdd23aede6d811561834bd833f707e3c1d517e53
IEDL.DBID AIKHN
ISSN 0022-3476
IngestDate Fri Oct 25 22:07:09 EDT 2024
Fri Dec 06 04:49:11 EST 2024
Sat Sep 28 07:54:36 EDT 2024
Sun Oct 22 16:07:40 EDT 2023
Wed Dec 27 19:18:10 EST 2023
Fri Feb 23 02:30:25 EST 2024
Tue Oct 15 22:54:03 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords MERLIN
Medical Emergency Relief International
IOM
HCV
NHANES
Institute of Medicine
Hepatitis C virus
National Health and Nutrition Examination Survey
Sustained virologic response
SVR
Human
Pediatrics
Rate
Hepatic disease
Epidemiology
Infection
Survey
Treatment
Surveillance
Viral disease
Digestive diseases
Child
Public health
Viral hepatitis C
Language English
License CC BY 4.0
Copyright © 2012. Published by Mosby, Inc.
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c468t-9822c0064913c832ab91f442dcdd23aede6d811561834bd833f707e3c1d517e53
Notes http://dx.doi.org/10.1016/j.jpeds.2012.05.002
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 22765955
PQID 1115528423
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1115528423
crossref_primary_10_1016_j_jpeds_2012_05_002
pubmed_primary_22765955
pascalfrancis_primary_26507483
fao_agris_US201500087688
elsevier_sciencedirect_doi_10_1016_j_jpeds_2012_05_002
elsevier_clinicalkeyesjournals_1_s2_0_S0022347612005057
PublicationCentury 2000
PublicationDate 2012-11-01
PublicationDateYYYYMMDD 2012-11-01
PublicationDate_xml – month: 11
  year: 2012
  text: 2012-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Maryland Heights, MO
PublicationPlace_xml – name: Maryland Heights, MO
– name: United States
PublicationTitle The Journal of pediatrics
PublicationTitleAlternate J Pediatr
PublicationYear 2012
Publisher Elsevier Inc
Mosby, Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Mosby, Inc
– name: Elsevier
References Casiraghi, De Paschale, Romano, Biffi, Assi, Binelli (bib25) 2004; 39
El-Hawary, El-Raziky, Esmat, Soliman, Abouzied, El-Raziky (bib9) 2007; 13
Swan, Long, Carr, Flanagan, Irish, Keating (bib19) 2010; 24
Scott, Wald, Kitahata, Krantz, Drolette, Corey (bib22) 2009; 23
Strickland, Jenkins, Hudson (bib12) 2001; 23
Armstrong, Wasley, Simard, McQuillan, Kuhnert, Alter (bib23) 2006; 144
Shneider, Gonzalez-Peralta, Roberts (bib28) 2006; 44
Craxi, Laffi, Zignego (bib30) 2008; 29
Bortolotti, Verucchi, Camma, Cabibbo, Zancan, Indolfi (bib11) 2008; 134
Poordad, McCone, Bacon, Bruno, Manns, Sulkowski (bib17) 2011; 364
Mitchell, Colvin, Palmer Beasley (bib2) 2010; 51
Badizadegan, Jonas, Ott, Nelson, Perez-Atayde (bib8) 1998; 28
Puchner, Berg (bib31) 2009; 47
Gonzalez-Peralta, Langham, Andres, Mohan, Colombani, Alford (bib13) 2009; 48
(bib1) 2000; 75
Minola, Prati, Suter, Maggiolo, Caprioli, Sonzogni (bib24) 2002; 99
Kage, Fujisawa, Shiraki, Tanaka, Kimura, Shimamatsu (bib6) 1997; 26
Garcia-Monzon, Jara, Fernandez-Bermejo, Hierro, Frauca, Camarena (bib7) 1998; 28
Jhaveri, Grant, Kauf, McHutchison (bib4) 2006; 148
Smith, Nelson, Naik, Woten (bib16) 2011; 45
Volk (bib27) 2010; 65
Alter, Kruszon-Moran, Nainan, McQuillan, Gao, Moyer (bib5) 1999; 341
Schwarz, Gonzalez-Peralta, Murray, Molleston, Haber, Jonas (bib14) 2011; 140
Sene, Limal, Cacoub (bib29) 2004; 19
Sherman, Flamm, Afdhal (bib18) 2010; 52
Wirth, Ribes-Koninckx, Calzado, Bortolotti, Zancan, Jara (bib15) 2010; 52
Davis, Alter, El-Serag, Poynard, Jennings (bib26) 2010; 138
Grebely, Genoway, Raffa, Dhadwal, Rajan, Showler (bib20) 2008; 93
Goodman, Makhlouf, Liu, Balistreri, Gonzalez-Peralta, Haber (bib10) 2008; 47
Yan, Wong, Wong, Chan (bib21) 2010; 55
Lavanchy (bib3) 2009; 29
Alter (10.1016/j.jpeds.2012.05.002_bib5) 1999; 341
Strickland (10.1016/j.jpeds.2012.05.002_bib12) 2001; 23
Schwarz (10.1016/j.jpeds.2012.05.002_bib14) 2011; 140
Scott (10.1016/j.jpeds.2012.05.002_bib22) 2009; 23
Mitchell (10.1016/j.jpeds.2012.05.002_bib2) 2010; 51
Goodman (10.1016/j.jpeds.2012.05.002_bib10) 2008; 47
Puchner (10.1016/j.jpeds.2012.05.002_bib31) 2009; 47
Shneider (10.1016/j.jpeds.2012.05.002_bib28) 2006; 44
(10.1016/j.jpeds.2012.05.002_bib1) 2000; 75
Bortolotti (10.1016/j.jpeds.2012.05.002_bib11) 2008; 134
Davis (10.1016/j.jpeds.2012.05.002_bib26) 2010; 138
Sherman (10.1016/j.jpeds.2012.05.002_bib18) 2010; 52
Craxi (10.1016/j.jpeds.2012.05.002_bib30) 2008; 29
El-Hawary (10.1016/j.jpeds.2012.05.002_bib9) 2007; 13
Badizadegan (10.1016/j.jpeds.2012.05.002_bib8) 1998; 28
Sene (10.1016/j.jpeds.2012.05.002_bib29) 2004; 19
Wirth (10.1016/j.jpeds.2012.05.002_bib15) 2010; 52
Garcia-Monzon (10.1016/j.jpeds.2012.05.002_bib7) 1998; 28
Swan (10.1016/j.jpeds.2012.05.002_bib19) 2010; 24
Lavanchy (10.1016/j.jpeds.2012.05.002_bib3) 2009; 29
Poordad (10.1016/j.jpeds.2012.05.002_bib17) 2011; 364
Smith (10.1016/j.jpeds.2012.05.002_bib16) 2011; 45
Jhaveri (10.1016/j.jpeds.2012.05.002_bib4) 2006; 148
Gonzalez-Peralta (10.1016/j.jpeds.2012.05.002_bib13) 2009; 48
Yan (10.1016/j.jpeds.2012.05.002_bib21) 2010; 55
Volk (10.1016/j.jpeds.2012.05.002_bib27) 2010; 65
Grebely (10.1016/j.jpeds.2012.05.002_bib20) 2008; 93
Kage (10.1016/j.jpeds.2012.05.002_bib6) 1997; 26
Minola (10.1016/j.jpeds.2012.05.002_bib24) 2002; 99
Casiraghi (10.1016/j.jpeds.2012.05.002_bib25) 2004; 39
Armstrong (10.1016/j.jpeds.2012.05.002_bib23) 2006; 144
References_xml – volume: 134
  start-page: 1900
  year: 2008
  end-page: 1907
  ident: bib11
  article-title: Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease
  publication-title: Gastroenterology
  contributor:
    fullname: Indolfi
– volume: 140
  start-page: 450
  year: 2011
  end-page: 458
  ident: bib14
  article-title: The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C
  publication-title: Gastroenterology
  contributor:
    fullname: Jonas
– volume: 148
  start-page: 353
  year: 2006
  end-page: 358
  ident: bib4
  article-title: The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period
  publication-title: J Pediatr
  contributor:
    fullname: McHutchison
– volume: 26
  start-page: 771
  year: 1997
  end-page: 775
  ident: bib6
  article-title: Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan
  publication-title: Hepatology
  contributor:
    fullname: Shimamatsu
– volume: 65
  start-page: 1327
  year: 2010
  end-page: 1329
  ident: bib27
  article-title: Antiviral therapy for hepatitis C: why are so few patients being treated?
  publication-title: J Antimicrob Chemother
  contributor:
    fullname: Volk
– volume: 19
  start-page: 357
  year: 2004
  end-page: 381
  ident: bib29
  article-title: Hepatitis C virus-associated extrahepatic manifestations: a review
  publication-title: Metab Brain Dis
  contributor:
    fullname: Cacoub
– volume: 28
  start-page: 1696
  year: 1998
  end-page: 1701
  ident: bib7
  article-title: Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients
  publication-title: Hepatology
  contributor:
    fullname: Camarena
– volume: 23
  start-page: 925
  year: 2009
  end-page: 929
  ident: bib22
  article-title: Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
  publication-title: AIDS Patient Care STDS
  contributor:
    fullname: Corey
– volume: 52
  start-page: 501
  year: 2010
  end-page: 507
  ident: bib15
  article-title: High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin
  publication-title: J Hepatol
  contributor:
    fullname: Jara
– volume: 44
  start-page: 1344
  year: 2006
  end-page: 1354
  ident: bib28
  article-title: Controversies in the management of pediatric liver disease: hepatitis B, C, and NAFLD: summary of a single topic conference
  publication-title: Hepatology
  contributor:
    fullname: Roberts
– volume: 23
  start-page: 527
  year: 2001
  end-page: 529
  ident: bib12
  article-title: Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer
  publication-title: J Pediatr Hematol Oncol
  contributor:
    fullname: Hudson
– volume: 24
  start-page: 753
  year: 2010
  end-page: 762
  ident: bib19
  article-title: Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration
  publication-title: AIDS Patient Care STDS
  contributor:
    fullname: Keating
– volume: 47
  start-page: 836
  year: 2008
  end-page: 843
  ident: bib10
  article-title: Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial
  publication-title: Hepatology
  contributor:
    fullname: Haber
– volume: 364
  start-page: 1195
  year: 2011
  end-page: 1206
  ident: bib17
  article-title: Boceprevir for untreated chronic HCV genotype 1 infection
  publication-title: N Engl J Med
  contributor:
    fullname: Sulkowski
– volume: 45
  start-page: 639
  year: 2011
  end-page: 648
  ident: bib16
  article-title: Telaprevir: An NS3/4A protease inhibitor for the treatment of chronic hepatitis C
  publication-title: Ann Pharmacother
  contributor:
    fullname: Woten
– volume: 29
  start-page: 85
  year: 2008
  end-page: 95
  ident: bib30
  article-title: Hepatitis C virus (HCV) infection: a systemic disease
  publication-title: Mol Aspects Med
  contributor:
    fullname: Zignego
– volume: 28
  start-page: 1416
  year: 1998
  end-page: 1423
  ident: bib8
  article-title: Histopathology of the liver in children with chronic hepatitis C viral infection
  publication-title: Hepatology
  contributor:
    fullname: Perez-Atayde
– volume: 52
  year: 2010
  ident: bib18
  article-title: Telaprevir in combination with peg-interferon alfa2a and ribavirin for 24 or 48 weeks in treatment-naive genotype 1 HCV patients who achieved an extended rapid viral response: Final results of phase 3 ILLUMINATE study
  publication-title: Hepatology
  contributor:
    fullname: Afdhal
– volume: 341
  start-page: 556
  year: 1999
  end-page: 562
  ident: bib5
  article-title: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
  publication-title: N Engl J Med
  contributor:
    fullname: Moyer
– volume: 55
  start-page: 3541
  year: 2010
  end-page: 3547
  ident: bib21
  article-title: Rate and factors affecting treatment uptake of patients with chronic hepatitis C in a tertiary referral hospital
  publication-title: Dig Dis Sci
  contributor:
    fullname: Chan
– volume: 29
  start-page: 74
  year: 2009
  end-page: 81
  ident: bib3
  article-title: The global burden of hepatitis C
  publication-title: Liver Int
  contributor:
    fullname: Lavanchy
– volume: 144
  start-page: 705
  year: 2006
  end-page: 714
  ident: bib23
  article-title: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
  publication-title: Ann Intern Med
  contributor:
    fullname: Alter
– volume: 48
  start-page: 630
  year: 2009
  end-page: 635
  ident: bib13
  article-title: Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C
  publication-title: J Pediatr Gastroenterol Nutr
  contributor:
    fullname: Alford
– volume: 51
  start-page: 729
  year: 2010
  end-page: 733
  ident: bib2
  article-title: Institute of Medicine recommendations for the prevention and control of hepatitis B and C
  publication-title: Hepatology
  contributor:
    fullname: Palmer Beasley
– volume: 138
  start-page: 513
  year: 2010
  end-page: 521
  ident: bib26
  article-title: Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression
  publication-title: Gastroenterology
  contributor:
    fullname: Jennings
– volume: 13
  start-page: 2846
  year: 2007
  end-page: 2851
  ident: bib9
  article-title: Assessment of hepatic fibrosis in pediatric cases with hepatitis C virus in Egypt
  publication-title: World J Gastroenterol
  contributor:
    fullname: El-Raziky
– volume: 93
  start-page: 141
  year: 2008
  end-page: 147
  ident: bib20
  article-title: Barriers associated with the treatment of hepatitis C virus infection among illicit drug users
  publication-title: Drug Alcohol Depend
  contributor:
    fullname: Showler
– volume: 47
  start-page: 446
  year: 2009
  end-page: 456
  ident: bib31
  article-title: Extrahepatic manifestations of chronic hepatitis C virus infection
  publication-title: Z Gastroenterol
  contributor:
    fullname: Berg
– volume: 39
  start-page: 90
  year: 2004
  end-page: 96
  ident: bib25
  article-title: Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini-transfusions of blood given at birth
  publication-title: Hepatology
  contributor:
    fullname: Binelli
– volume: 99
  start-page: 4588
  year: 2002
  end-page: 4591
  ident: bib24
  article-title: Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C
  publication-title: Blood
  contributor:
    fullname: Sonzogni
– volume: 75
  start-page: 18
  year: 2000
  end-page: 19
  ident: bib1
  article-title: Hepatitis C—global prevalence (update)
  publication-title: Wkly Epidemiol Rec
– volume: 23
  start-page: 527
  year: 2001
  ident: 10.1016/j.jpeds.2012.05.002_bib12
  article-title: Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer
  publication-title: J Pediatr Hematol Oncol
  doi: 10.1097/00043426-200111000-00012
  contributor:
    fullname: Strickland
– volume: 29
  start-page: 85
  year: 2008
  ident: 10.1016/j.jpeds.2012.05.002_bib30
  article-title: Hepatitis C virus (HCV) infection: a systemic disease
  publication-title: Mol Aspects Med
  doi: 10.1016/j.mam.2007.09.017
  contributor:
    fullname: Craxi
– volume: 29
  start-page: 74
  issue: Suppl 1
  year: 2009
  ident: 10.1016/j.jpeds.2012.05.002_bib3
  article-title: The global burden of hepatitis C
  publication-title: Liver Int
  doi: 10.1111/j.1478-3231.2008.01934.x
  contributor:
    fullname: Lavanchy
– volume: 28
  start-page: 1416
  year: 1998
  ident: 10.1016/j.jpeds.2012.05.002_bib8
  article-title: Histopathology of the liver in children with chronic hepatitis C viral infection
  publication-title: Hepatology
  doi: 10.1002/hep.510280534
  contributor:
    fullname: Badizadegan
– volume: 341
  start-page: 556
  year: 1999
  ident: 10.1016/j.jpeds.2012.05.002_bib5
  article-title: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199908193410802
  contributor:
    fullname: Alter
– volume: 19
  start-page: 357
  year: 2004
  ident: 10.1016/j.jpeds.2012.05.002_bib29
  article-title: Hepatitis C virus-associated extrahepatic manifestations: a review
  publication-title: Metab Brain Dis
  doi: 10.1023/B:MEBR.0000043982.17294.9b
  contributor:
    fullname: Sene
– volume: 44
  start-page: 1344
  year: 2006
  ident: 10.1016/j.jpeds.2012.05.002_bib28
  article-title: Controversies in the management of pediatric liver disease: hepatitis B, C, and NAFLD: summary of a single topic conference
  publication-title: Hepatology
  doi: 10.1002/hep.21373
  contributor:
    fullname: Shneider
– volume: 26
  start-page: 771
  year: 1997
  ident: 10.1016/j.jpeds.2012.05.002_bib6
  article-title: Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan
  publication-title: Hepatology
  doi: 10.1002/hep.510260333
  contributor:
    fullname: Kage
– volume: 28
  start-page: 1696
  year: 1998
  ident: 10.1016/j.jpeds.2012.05.002_bib7
  article-title: Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients
  publication-title: Hepatology
  doi: 10.1002/hep.510280633
  contributor:
    fullname: Garcia-Monzon
– volume: 45
  start-page: 639
  year: 2011
  ident: 10.1016/j.jpeds.2012.05.002_bib16
  article-title: Telaprevir: An NS3/4A protease inhibitor for the treatment of chronic hepatitis C
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1P430
  contributor:
    fullname: Smith
– volume: 144
  start-page: 705
  year: 2006
  ident: 10.1016/j.jpeds.2012.05.002_bib23
  article-title: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-144-10-200605160-00004
  contributor:
    fullname: Armstrong
– volume: 23
  start-page: 925
  year: 2009
  ident: 10.1016/j.jpeds.2012.05.002_bib22
  article-title: Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
  publication-title: AIDS Patient Care STDS
  doi: 10.1089/apc.2009.0099
  contributor:
    fullname: Scott
– volume: 148
  start-page: 353
  year: 2006
  ident: 10.1016/j.jpeds.2012.05.002_bib4
  article-title: The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2005.10.031
  contributor:
    fullname: Jhaveri
– volume: 55
  start-page: 3541
  year: 2010
  ident: 10.1016/j.jpeds.2012.05.002_bib21
  article-title: Rate and factors affecting treatment uptake of patients with chronic hepatitis C in a tertiary referral hospital
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-010-1412-1
  contributor:
    fullname: Yan
– volume: 140
  start-page: 450
  year: 2011
  ident: 10.1016/j.jpeds.2012.05.002_bib14
  article-title: The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2010.10.047
  contributor:
    fullname: Schwarz
– volume: 39
  start-page: 90
  year: 2004
  ident: 10.1016/j.jpeds.2012.05.002_bib25
  article-title: Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini-transfusions of blood given at birth
  publication-title: Hepatology
  doi: 10.1002/hep.20030
  contributor:
    fullname: Casiraghi
– volume: 47
  start-page: 836
  year: 2008
  ident: 10.1016/j.jpeds.2012.05.002_bib10
  article-title: Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial
  publication-title: Hepatology
  doi: 10.1002/hep.22094
  contributor:
    fullname: Goodman
– volume: 52
  start-page: 501
  year: 2010
  ident: 10.1016/j.jpeds.2012.05.002_bib15
  article-title: High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.01.016
  contributor:
    fullname: Wirth
– volume: 138
  start-page: 513
  year: 2010
  ident: 10.1016/j.jpeds.2012.05.002_bib26
  article-title: Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2009.09.067
  contributor:
    fullname: Davis
– volume: 99
  start-page: 4588
  year: 2002
  ident: 10.1016/j.jpeds.2012.05.002_bib24
  article-title: Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C
  publication-title: Blood
  doi: 10.1182/blood-2001-12-0192
  contributor:
    fullname: Minola
– volume: 47
  start-page: 446
  year: 2009
  ident: 10.1016/j.jpeds.2012.05.002_bib31
  article-title: Extrahepatic manifestations of chronic hepatitis C virus infection
  publication-title: Z Gastroenterol
  doi: 10.1055/s-0028-1109296
  contributor:
    fullname: Puchner
– volume: 13
  start-page: 2846
  year: 2007
  ident: 10.1016/j.jpeds.2012.05.002_bib9
  article-title: Assessment of hepatic fibrosis in pediatric cases with hepatitis C virus in Egypt
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v13.i20.2846
  contributor:
    fullname: El-Hawary
– volume: 52
  issue: Suppl:400A-400A
  year: 2010
  ident: 10.1016/j.jpeds.2012.05.002_bib18
  article-title: Telaprevir in combination with peg-interferon alfa2a and ribavirin for 24 or 48 weeks in treatment-naive genotype 1 HCV patients who achieved an extended rapid viral response: Final results of phase 3 ILLUMINATE study
  publication-title: Hepatology
  contributor:
    fullname: Sherman
– volume: 93
  start-page: 141
  year: 2008
  ident: 10.1016/j.jpeds.2012.05.002_bib20
  article-title: Barriers associated with the treatment of hepatitis C virus infection among illicit drug users
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2007.09.008
  contributor:
    fullname: Grebely
– volume: 134
  start-page: 1900
  year: 2008
  ident: 10.1016/j.jpeds.2012.05.002_bib11
  article-title: Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.02.082
  contributor:
    fullname: Bortolotti
– volume: 24
  start-page: 753
  year: 2010
  ident: 10.1016/j.jpeds.2012.05.002_bib19
  article-title: Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration
  publication-title: AIDS Patient Care STDS
  doi: 10.1089/apc.2010.0142
  contributor:
    fullname: Swan
– volume: 75
  start-page: 18
  year: 2000
  ident: 10.1016/j.jpeds.2012.05.002_bib1
  article-title: Hepatitis C—global prevalence (update)
  publication-title: Wkly Epidemiol Rec
– volume: 48
  start-page: 630
  year: 2009
  ident: 10.1016/j.jpeds.2012.05.002_bib13
  article-title: Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/MPG.0b013e318170af04
  contributor:
    fullname: Gonzalez-Peralta
– volume: 51
  start-page: 729
  year: 2010
  ident: 10.1016/j.jpeds.2012.05.002_bib2
  article-title: Institute of Medicine recommendations for the prevention and control of hepatitis B and C
  publication-title: Hepatology
  doi: 10.1002/hep.23561
  contributor:
    fullname: Mitchell
– volume: 364
  start-page: 1195
  year: 2011
  ident: 10.1016/j.jpeds.2012.05.002_bib17
  article-title: Boceprevir for untreated chronic HCV genotype 1 infection
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1010494
  contributor:
    fullname: Poordad
– volume: 65
  start-page: 1327
  year: 2010
  ident: 10.1016/j.jpeds.2012.05.002_bib27
  article-title: Antiviral therapy for hepatitis C: why are so few patients being treated?
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkq157
  contributor:
    fullname: Volk
SSID ssj0009400
Score 2.3334832
Snippet Objective To evaluate the rate of pediatric hepatitis C virus (HCV) case ascertainment relative to the estimated number of actual cases. Study design Data from...
To evaluate the rate of pediatric hepatitis C virus (HCV) case ascertainment relative to the estimated number of actual cases. Data from Florida and United...
OBJECTIVE: To evaluate the rate of pediatric hepatitis C virus (HCV) case ascertainment relative to the estimated number of actual cases. STUDY DESIGN: Data...
OBJECTIVETo evaluate the rate of pediatric hepatitis C virus (HCV) case ascertainment relative to the estimated number of actual cases.STUDY DESIGNData from...
SourceID proquest
crossref
pubmed
pascalfrancis
fao
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 915
SubjectTerms Adolescent
Biological and medical sciences
Child
children
Epidemiology
Female
Florida
General aspects
health care costs
Health Surveys
Hepacivirus - metabolism
hepatitis C
Hepatitis C - diagnosis
Hepatitis C - epidemiology
Hepatitis C - therapy
Hepatitis C Antibodies - immunology
Hepatitis C virus
Human viral diseases
Humans
Infectious Disease Medicine - methods
Infectious diseases
Male
Medical sciences
morbidity
mortality
national surveys
Nutrition Surveys
Pediatrics
Pediatrics - methods
Prevalence
public health
Public Health - methods
Public health. Hygiene
Public health. Hygiene-occupational medicine
questionnaires
risk groups
United States
Viral diseases
Viral hepatitis
Title Expected and Actual Case Ascertainment and Treatment Rates for Children Infected with Hepatitis C in Florida and the United States: Epidemiologic Evidence from Statewide and Nationwide Surveys
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0022347612005057
https://dx.doi.org/10.1016/j.jpeds.2012.05.002
https://www.ncbi.nlm.nih.gov/pubmed/22765955
https://search.proquest.com/docview/1115528423
Volume 161
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa6rYS4VLybAisjcSR083CccFtFXW1B7YF2pd4sv4LSQ3bV7MKtv42fxoztNKp4HDgmsfOa8cxne-YbQt4rcIJMSRkDlOcx8pPEoCUqNg1MiAo-k9ZRCp1fFMtV_vmaXe-ResiFwbDKYPu9TXfWOpw5CX_zZNO2mOMLri2HaXjqyrHxCTkAd4R7tQfzsy_Li5F7Nw-ZKBi4Dh0G8iEX5nWzsQZpu3FNcFxe-YODmjRyjZGTsoef1_iqF3-Hpc49LZ6Qw4Ar6dy_-lOyZ7tn5NF52Dl_Tn4ip7EGeEllZ-jcpY3QGlwYnfd6DAtwV6-G4HP6FZEoBVxL65D0Tc9c9BbcB1dw6dJiRPa27WlN244uMJ7PSHcXQJbUI1rqEe0nejqWo201HQqaUkxx8W1-wBnX2dN1u8PL3e13ULcXZLU4vaqXcajeEOu8KLcxEgNqRDxVkmmwG1JVSZPnqdHGpJm0xhamBDxagFHJlSmzrOEzbjOdGJZwy7KXZL9bd_aIUJ4yyRCLVJblxiollTa6kEzxyhhdReTDIDKx8SQdYoheuxFOwgIlLGZMgIQjwgexiiH_FCym7cPw7UUiemgsflOxiBT3PR9oqQAH9O9HHoH6CPkNLLdYXaa4zuTYAMsyItMHOnX_BSmAZ56XWUTeDUomYOzjho7s7HrX4-yNMcAXKbR55bVv7J1ypIpkx__7yq_JYzzyeZdvyP72dmffAgDbqimZfLxLpmGY_QIXqC5J
link.rule.ids 314,780,784,4502,24116,27924,27925,45585,45679
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECWSFGh7KbpHSZuyQI9VYy0UpdwMIYbTxjk0NpAbwU2FcpCNyG5u-bZ8WmdIyULQ5dCjJVKWxOHMI_XmDSGfFARBpqQMAcrzEPVJQrASFZoKFkQZH0nrJIVmF9l0kX69Ylc7pOxzYZBW2fl-79Odt-6OHHdv83hV15jjC6EthWV47Mqx8V3yKGWAfsGov9wNPA-s_L2VDIfmvfSQI3ldr6xB0W7cERw2V_4QnnYruUTepGzh1VW-5sXfQakLTpPn5FmHKunY3_gLsmObl-TxrPtu_orco6KxBnBJZWPo2CWN0BICGB23eiAFuLPznnpOvyMOpYBqadmlfNMzx92C6-D-LZ1a5GOv65aWtG7oBNl8RrqrAK6kHs9Sj2dP6OlQjLbWtC9nSjHBxbe5hSOusxfrdj8vNzc_wdhek8XkdF5Ow652Q6jTLF-HKAuoEe8UUaLBa0hVRFWaxkYbEyfSGpuZHNBoBi4lVSZPkoqPuE10ZFjELUvekL1m2dh9QnnMJEMkUliWGquUVNroTDLFC2N0EZDP_ZCJlZfoED137Vq4ERY4wmLEBIxwQHg_rKLPPgV_adtu8rYiEi00Fr8ZWECybc8HNiog_Pz7L_fBfIT8AX5bLC5j3GVyWoB5HpCjBza1fYIYoDNP8yQgH3sjEzDz8XOObOxy0-LajTFAFzG0eeutb-gdcxSKZAf_e8sfyJPpfHYuzs8uvh2Sp3jGZ2C-I3vrm419D1BsrY7cVPsF3VMvIg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expected+and+Actual+Case+Ascertainment+and+Treatment+Rates+for+Children+Infected+with+Hepatitis+C+in+Florida+and+the+United+States%3A+Epidemiologic+Evidence+from+Statewide+and+Nationwide+Surveys&rft.jtitle=The+Journal+of+pediatrics&rft.au=Delgado-Borrego%2C+Aymin&rft.au=Smith%2C+Lesley&rft.au=Jonas%2C+Maureen+M.&rft.au=Hall%2C+Cyndena+A.&rft.date=2012-11-01&rft.pub=Elsevier+Inc&rft.issn=0022-3476&rft.eissn=1097-6833&rft.volume=161&rft.issue=5&rft.spage=915&rft.epage=921&rft_id=info:doi/10.1016%2Fj.jpeds.2012.05.002&rft.externalDocID=S0022347612005057
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00223476%2FS0022347612X00106%2Fcov150h.gif